Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population

Clinical Therapeutics

Volumn 27, Issue 5, 2005, Pages 630-645

  Fernandes, Ancilla W ^a   Madhavan, S Suresh ^b   Amonkar, Mayur M ^a  

^a GLAXOSMITHKLINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

ACC AHA guidelines; AMI; And utilization; Beta blockers; Fatality; Inappropriate prescribing; Medicaid; Secondary prevention; Utilization

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CHI SQUARE DISTRIBUTION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG MISUSE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH STATUS; HEART DEATH; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAID; MORTALITY; PRESCRIPTION; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; UNITED STATES;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANTIHYPERTENSIVE AGENTS; DRUG UTILIZATION; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MEDICAID; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSICIAN'S PRACTICE PATTERNS; TREATMENT OUTCOME;

EID: 20644455756     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2005.04.013     Document Type: Article

References (32)

1. Bellenir K Heart Diseases and Disorders Sourcebook 2nd ed 2000 Omnigraphics, Inc Detroit, Mich
2. Kochanek KD, and Smith BL Deaths: Preliminary data for 2002 Natl Vital Stat Rep 52 2004 1 47
3. Bradford WD, Chen J, and Krumholz HM Under-utilisation of beta-blockers after acute myocardial infarction. Pharmacoeconomic implications PharmacoEconomics 15 1999 257 268
4. Snow PJ Effect of propranolol in myocardial infarction Lancet 2 1965 551 553
5. Ryan TJ, Anderson JL, and Antman EM ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) J Am Coll Cardiol 28 1996 1328 1428
6. Brand DA, Newcomer LN, Freiburger A, and Tian H Cardiologists' practices compared with practice guidelines: Use of beta-blockade after acute myocardial infarction J Am Coll Card 26 1995 1432 1436
7. Schmader KE, Hanlon JT, and Landsman PB Inappropriate prescribing and health outcomes in elderly veteran outpatients Ann Pharmacother 31 1997 529 533
8. Krumholz HM, Radford MJ, and Wang Y National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project [publised correction appears in JAMA. 1999;281:37] JAMA 280 1998 623 629
9. Soumerai SB, McLaughlin TJ, and Spiegelman D Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction JAMA 277 1997 115 121
10. Shireman TI, Heaton PC, and Gay WE Relationship between asthma drug therapy patterns and healthcare utilization Ann Pharmacother 36 2002 557 564
11. Anis AH, Lynd LD, and Wang XH Double trouble: Impact of inappropriate use of asthma medication on the use of health care resources CMAJ 164 2001 625 631
12. Stroupe KT, Murray MD, Stump TE, and Callahan CM Association between medication supplies and healthcare costs in older adults from an urban healthcare system J Am Geriatr Soc 48 2000 760 768
13. International Classification of Diseases, Ninth Revision, Clinical Modification 6th ed. 2003 US Dept of Health and Human Services, Centers for Disease Control and Prevention, Centers for Medicare and Medicaid Services Washington, DC
14. Current Procedural Terminology: CPT 2002 2001 American Medical Association Chicago, III
15. National Drug Code Directory 2003 US Food and Drug Administration Center for Drug Evaluation and Research Rockville, MD
16. Health Insurance Portability and Accountability Act of 1996, 42 USC §1320-d2.
17. Halverson R, and Palmquist R The interpretation of dummy variables in semi-logarithmic equations Am Econ Rev 70 1980 474 475
18. Letter Kennedy P Estimation with correctly interpreted dummy variables in semi-logarithmic equations Am Econ Rev 71 1981 801
19. Myers RH Classical and Modern Regression with Applications 2nd ed. 1990 PWS-Kent Boston, Mass
20. Johnston J DiNardo J Heteroscedasticity and autocorrelation 4th ed. Econometric Methods 1997 McGraw Hill New York 162 203
21. Stevens J Applied Multivariate Statistics for the Social Sciences 3rd ed. 1996 Lawrence Erlbaum Associates Mahwah, NJ
22. White H A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity Econometrica 48 1980 817 838
23. D'Agostino RB Jr Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 1998 2265 2281
24. Schade CP, Brehm JG, Stephens MK, and Rezek G Beta blocker use in acute myocardial infarction in West Virginia W V Med J 98 2002 56 60
25. Sial SH, Malone M, and Freeman JL Beta blocker use in the treatment of community hospital patients discharged after myocardial infarction J Gen Intern Med 9 1994 599 605
26. Goldstein S Beta-blockers in hypertensive and coronary heart disease Arch Intern Med 156 1996 1267 1276
27. Yusuf S, Peto R, and Lewis J Beta blockade during and after myocardial infarction: An overview of the randomized trials Prog Cardiovasc Dis 27 1985 335 371
28. National Diabetes Data Group Diabetes in America 2nd ed. NIH publication 95-1468 1995 US Dept of Health and Human Services, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases Washington, DC
29. Ahdout DJ, Daman PM, and Ultan LB Recurrent acute pulmonary emboli in association with acute myocardial infarction Chest 96 1989 682 684
30. Carson JL, Kelley MA, and Duff A The clinical course of pulmonary embolism N Engl J Med 326 1992 1240 1245
31. for the ROSETTA Investigators Tsang J, Sheppard R, and Mak KH Six-month outcomes of percutaneous transluminal coronary angioplasty in hypertensive patients: Results from the ROSETTA registry. Routine Versus Selective Exercise Treadmill Testing After Angioplasty Am Heart J 143 2002 124 129
32. Antman EM, Anbe DT, and Armstrong PW ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction) for the American College of Cardiology; American Heart Association; Canadian Cardiovascular Society J Am Coll Cardiol 44 2004 671 719